Grant Amy, Crane Melissa, Laupacis Andreas, Griffiths Anne, Burnett Dave, Hood Amanda, Kluthe Cheryl, Maghera Muneet, Mann Malcolm, Mansi Melissa, Murray Kate, Trempe Marie-Josée, Otley Anthony
Maritime Intestinal Research Alliance (MIRA), IWK Health Centre, Halifax, Nova Scotia.
Li Ka Shing Knowledge Institute, St. Michael's Hospital.
J Pediatr Gastroenterol Nutr. 2019 Sep;69(3):317-323. doi: 10.1097/MPG.0000000000002396.
Including individuals with lived experience in pediatric inflammatory bowel disease (IBD) is essential to establishing a research agenda that is mutually impactful to both those treating and those experiencing the disease.
Using the James Lind Alliance approach to research priority setting, a 10-member steering committee composed of current and former pediatric patients with IBD, caregivers, and clinicians was formed. A national survey, disseminated across Canada, elicited uncertainties which were divided into unanswered and answered research questions. Subsequently a research prioritization survey was disseminated where respondents ranked their top 20 research uncertainties. A final prioritization meeting was held to agree upon the top 10 uncertainties.
From 1209 research questions submitted by 363 participants, the list was reduced to 105 indicative questions that were within scope and deemed unanswered in the literature. Via the national research prioritization survey, this list was further reduced. The top 10 uncertainties identified at the final research consensus meeting, with 21 participants from all stakeholder groups, included "What are the causes of IBD?," "Can IBD be prevented?," "What role does diet have in the management of pediatric IBD?." Other questions concerned flare ups, biomarkers, optimal patient education, long-term effects of medication and early-diagnosis, role of psychological support, and optimal approach to diagnosis.
This research adds a unique perspective by deriving a list of pediatric IBD research uncertainties important by patients and caregivers and clinicians.
让有小儿炎症性肠病(IBD)亲身经历的个体参与进来,对于制定一个对治疗该病的人员和患病人员都有相互影响的研究议程至关重要。
采用詹姆斯·林德联盟确定研究重点的方法,成立了一个由现任和前任患IBD的儿科患者、护理人员及临床医生组成的10人指导委员会。在加拿大全国范围内开展了一项调查,收集不确定性问题,这些问题被分为未回答的和已回答的研究问题。随后开展了一项研究优先级调查,让受访者对他们最关心的20个研究不确定性问题进行排序。最后召开了一次优先级确定会议,以商定前10个不确定性问题。
从363名参与者提交的1209个研究问题中,筛选出了105个符合范围且在文献中被视为未回答的指示性问题。通过全国性的研究优先级调查,这个列表进一步缩减。在最终的研究共识会议上,来自所有利益相关群体的21名参与者确定的前10个不确定性问题包括“IBD的病因是什么?”“IBD能否预防?”“饮食在小儿IBD管理中起什么作用?”其他问题涉及病情发作、生物标志物、最佳患者教育、药物的长期影响和早期诊断、心理支持的作用以及最佳诊断方法。
本研究通过得出一份对患者、护理人员和临床医生而言都很重要的小儿IBD研究不确定性问题清单,增添了独特的视角。